Gain Corporation is rated a hold after exceeding my initial price target and experiencing a sharp post-earnings selloff.

Palantir stock is a "Strong Buy" given its growth and EPS outlook, despite a premium valuation. Here's what investors need to ...

From artificial intelligence-driven efficiency to transmission bottlenecks, power industry insiders share their perspectives ...

Suunto’s newest adventure watch finally bridges power and polish—with GPS accuracy, off-grid mapping, and battery life that ...

An overview of the direct lending market, including the characteristics of direct lending that distinguish it from the ...

The tangible changes included the demolition of old workshops, the "retirement" of towering smokestacks, the adoption of ...

OpenAI offers app integrations in ChatGPT to allow you to connect your accounts directly to ChatGPT and ask the assistant to do things for you.

AI-powered integrations and features in modern bookkeeping software like QuickBooks can make account reconciliation easier, ...

Plenty of Americans want more money without signing up for a formal second job, so they are leaning on flexible side-income ...

My in-depth Godel Terminal Review covers pricing, core features, data speed, pros and cons, and how it stacks up against ...

Geopolitical tensions, ETF moves & major headlines shape the crypto weekly market wrap of January 5 as Bitcoin tops $90K.

Using the 2 Stage Free Cash Flow to Equity, OKYO Pharma fair value estimate is US$4.57. OKYO Pharma's US$2.40 share price signals that it might be 47% undervalued. O ...